K18-hACE2 transgenic mice express human ACE2 driven by the epithelial K18 promoter and thus develop severe SARS-like inflammatory lung injury and immune dysregulation after SARS-CoV-2 infection17. The gene discussed is KRT18; the disease is COVID-19.